Translations:SGLT2 inhibitor/1/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
14,847 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 19:46, 12 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (SGLT2 inhibitor)
{{Drug List/ja|state6=uncollapsed}}
{{Pathnav|Medication|Diabetes medication|frame=1}}
{| class="wikitable sortable" style="width:100%"
|-
!一般名
!先発名
!class="unsortable"| 日本
!創薬/開発
!備考
|-
|[[Ipragliflozin/ja]]
|[https://amn.astellas.jp/di/detail/sgl/index_sgl-25 スーグラ](Sugulat) ([https://amn.astellas.jp/common/pdfviewer.html/content/dam/jp/amn/jp/ja/di/doc/Pdfs/DocNo202211124_y.pdf PI]) ([https://amn.astellas.jp/common/pdfviewer.html/content/dam/jp/amn/jp/ja/di/doc/Pdfs/DocNo202311786_y.pdf IF])
|販売
|[[Astellas Pharma]]
|
|-
|}
Medication > Diabetes medication > SGLT2 inhibitor/1/en
一般名 先発名 日本 創薬/開発 備考
イプラグリフロジン スーグラ(Sugulat) (PI) (IF) 販売 Astellas Pharma
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:SGLT2_inhibitor/1/en&oldid=113830"